Canine Arthritis Treatment Market Outlook from 2024 to 2034
The global canine arthritis treatment market stands at a valuation of US$ 2.50 billion in 2024. Global demand for canine arthritis treatment medications is predicted to rise at a CAGR of 4.20% and attain a market valuation of US$ 3.77 billion by 2034.
Attributes
Key Statistics
Expected Base Year Value (2024)
US$ 2.50 billion
Anticipated Forecast Value (2034)
US$ 3.77 billion
Estimated Growth (2024 to 2034)
4.20% CAGR
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Key Market Drivers
The canine arthritis treatment industry generated a valuation of US$ 1.97 billion in 2018. The market grew at a rate of 5.0% CAGR over five years, generating an additional US$ 550 million in valuation by 2023.
This growth can be attributed to various factors:
Increased awareness among pet owners about the importance of arthritis management for their canine companions, leading to earlier diagnosis and treatment initiation
Advancements in veterinary pharmaceuticals, such as new pain management medications and joint supplements, provide more effective options for arthritis relief
Expansion of veterinary services offering specialized treatments like acupuncture, hydrotherapy, and physical therapy, improving access to comprehensive arthritis care for dogs
Growing demand for minimally invasive surgical procedures for arthritis treatment due to pet owners' desire for less invasive yet effective solutions
Rise in pet insurance coverage, allowing more pet owners to afford arthritis treatments for their dogs, driving increased utilization of veterinary services
Adoption of preventive healthcare measures to address arthritis risk factors early on, highlighting the importance of proactive management in maintaining canine joint health
Development of innovative technologies like regenerative medicine for arthritis treatment, promising novel approaches to alleviate joint pain and improve mobility in dogs
The aging pet population leading to a higher prevalence of arthritis cases, underscoring the need for ongoing advancements in arthritis management strategies
Increasing disposable income among pet owners, facilitating greater investment in advanced arthritis treatments, and enhancing the overall quality of care for arthritic dogs
Strong emphasis on improving the quality of life and mobility for arthritic dogs, driving demand for effective treatment options due to the evolving attitudes towards pets as valued family members.
Consumption Analysis of the Canine Arthritis Treatment Market
Sales of canine arthritis treatments are growing among veterinary professionals, veterinary technicians, and other staff members, who diagnose, prescribe, and administer arthritis treatments to dogs
Canine arthritis treatments are also experiencing increasing demand from pet owners who own dogs affected by arthritis and seek out treatments to improve their pets' comfort and quality of life
The growing adoption of canine arthritis treatments is also observed among et insurance companies that provide coverage for veterinary expenses and help pet owners afford necessary care for their arthritic dogs
Pet product retailers are also some of the largest consumer groups in this market. These entities seek arthritis treatments for their canine companions, providing access to medications, supplements, and other supportive products
Veterinary clinics and pet care facilities generate great demand for canine arthritis treatments. These entities utilize canine arthritis treatments to address joint pain and mobility issues in dogs under their care.
Find your sweet spots for generating winning opportunities in this market.
Hesitation Among Pet Owners to Slow Down the Market Growth for Canine Arthritis Treatments
The canine arthritis treatment market is anticipated to grow at a modest CAGR of 4.20% till 2034. This is attributed to several reasons:
Canine arthritis treatments, in most cases, are hindered due to limited access to affordable veterinary care in certain regions, especially the underdeveloped and developing parts of the world.
Some pet owners are hesitant to try new medications or therapies due to concerns regarding the safety and efficacy of certain arthritis treatments. This leads to potential gaps in treatment, slowing down the market.
Traditional pharmaceutical treatments for canine arthritis also face competition from alternative treatments such as physical therapy, acupuncture, and chiropractic care. This is significantly diverting the consumer base.
Limited awareness and education among pet owners about early intervention and long-term management of arthritis in dogs is resulting in delayed diagnosis. This is detrimental to the health of the pet, which has to undergo a lot of pain.
Comparative View of Adjacent Industries
Future Market Insights has comprehensively analyzed the global healthcare sector and has studied two markets alongside the canine arthritis treatment market--the veterinary vaccines market and the animal healthcare market. The growth rates and the current market valuation have been mentioned in the table below. The growth factors and critical challenges in the respective markets have also been discussed below.
Canine Arthritis Treatment Market:
Attributes
Canine Arthritis Treatment Market
CAGR (2024 to 2034)
4.20%
Market Value (2024)
US$ 2.50 billion
Growth Factor
Increased awareness among pet owners about the importance of arthritis management for their canine companions
Challenges
Hesitancy among pet owners to try new medications or therapies due to concerns regarding the safety and efficacy
Animal Healthcare Market:
Attributes
Animal Healthcare Market
CAGR (2023 to 2033)
4.30%
Market Value (2023)
US$ 40.9 billion
Growth Factor
Growing awareness about maintaining the proper health of animals, and surging demand for animal pharmaceuticals for enhancing the immunity system of animals.
Challenges
Increasing restrictions imposed by regulatory authorities in some countries on the usage of antibiotics
Veterinary Vaccines Market:
Attributes
Veterinary Vaccines Market
CAGR (2023 to 2033)
6.20%
Market Value (2022)
US$ 11.3 billion
Growth Factor
The rising prevalence of zoonotic diseases, increasing demand for animal products, and growing trend of pet adoption across the world
Challenges
The lack of awareness and accessibility for smaller farmers, low healthcare awareness in some regions, and the possibility of harmful outcomes of animal vaccinations
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Pet Owners are Increasingly Preferring NSAIDs for Canine Arthritis Treatments
The NSAIDs category is projected to hold the largest share of the canine arthritis treatment market in the year 2024. This segment holds the dominant market share, accounting for 72% of the global canine arthritis treatment market.
The demand for NSAIDs (Non-Steroidal Anti-Inflammatory Drugs) has skyrocketed in the last few decades as they are considered highly effective in relieving pain and inflammation associated with canine arthritis.
Veterinary professionals are also prescribing NSAIDs due to their proven effectiveness and safety profile in managing arthritis symptoms in dogs. This has made NSAIDs the most sought-after treatment option for pet owners.
Attributes
Details
Drug Class
NSAIDs
Market Share
72.00%
Veterinary Professionals are Prescribing Oral Treatments for Canine Arthritis
The canine arthritis treatment market is also categorized by route of administration into oral and injectable canine arthritis treatment. The oral segment dominates the market with a share of 70% in 2024.
Pet owners, as well as veterinary professionals, are increasingly choosing oral treatments as they offer a convenient administration route for them. This allows for easy integration into a dog's daily routine.
The demand for oral routes in canine arthritis treatments is also surging as they provide flexibility in dosing and administration schedules. This minimizes the risk of complications associated with injectable therapies, such as injection site reactions.
Attributes
Details
Route of Administration
Oral
Market Share
70.00%
Country-wise Insights
The section provides an analysis of the canine arthritis treatment market by country, including India, Spain, Italy, Australia, and France. The table presents the CAGR for each country, indicating the expected growth of the market in that country through 2034.
Countries
CAGR
Spain
5.50%
India
5.30%
Italy
4.90%
Australia
4.70%
France
4.60%
Growing Awareness about Arthritis in Dogs is pushing the Demand for Treatments in India
India is expected to exhibit significant market growth over the forecast period. The Indian market for canine arthritis treatments is anticipated to grow at a CAGR of 5.30% through 2034.
The growing awareness among Indian pet owners about the significance of veterinary care, including arthritis management, is driving the demand for treatment options.
The emerging middle class in India with more disposable income to spend on pet healthcare, including arthritis treatments. This is significantly fuelling market growth in the country.
Pet Humanization Trend to Boost Market Growth in Spain
Spain is also one of the lucrative markets in the canine arthritis treatment industry. The Spanish market for canine arthritis treatments is anticipated to grow at a CAGR of 5.50% through 2034.
Spain is witnessing a trend of pet humanization, where dogs are considered valued family members. This has resulted in an increased investment in their healthcare, including arthritis treatment.
The pet insurance market in Spain is also experiencing a significant surge in the recent past. This has helped pet owners afford expensive treatments, like arthritis subsequently contributing to the growth of this market.
Significant Population of Aging Dogs in Italy to Augment Market Growth
Italy also is a promising market in the global canine arthritis treatment industry. Over the next ten years, the Italian demand for canine arthritis treatments is projected to rise at a 4.90% CAGR.
The changing lifestyles in Italy, with more people living in urban areas and smaller homes, have led to an increased focus on pet health. This is also one of the main drivers for the exponential growth of this market in the country.
Italy has a significant population of aging dogs. This has led to a higher prevalence of arthritis and, thus, an increased demand for canine treatments in the country.
Pet-friendly Policies to Shape the Future of Canine Arthritis Market in Australia
Australia is also one of the countries that is filled with potential in this market. The Australian canine arthritis treatment market is anticipated to retain its dominance by progressing at a growth rate of 4.70% till 2034.
Australia's outdoor lifestyle contributes to a high level of physical activity for dogs. This has increased the risk of arthritis and, thus, driving demand for canine arthritis treatment options in the country.
Australia also has considerable pet-friendly policies and regulations. This encourages a supportive environment for pet healthcare, including arthritis treatment.
High-standard Veterinary Care to Boost the Market Growth in France
France also exhibits a promising future in the global canine arthritis treatment market. The canine arthritis treatment market in France is anticipated to retain its dominance by progressing at a growth rate of 4.60% till 2034.
France is known for its high standard of veterinary care, with skilled professionals offering advanced arthritis treatment solutions for dogs. This is one of the main reasons for the country’s position in the global market.
France's pet-friendly culture, with dogs being considered integral members of many households, also drives demand for arthritis treatment options.
Competitive Landscape
Major companies and manufacturers in the canine arthritis treatment market, such as Boehringer Ingelheim International GmbH., DAIICHI SANKYO COMPANY, LIMITED, Thorne, NUTRI-VET, American Regent, Inc., DSM, etc., investing heavily in research and development to innovate new medications, supplements, and therapeutic approaches.
These companies are also expanding their distribution networks and partnerships with veterinary clinics, pet retailers, and online platforms to enhance the market reach and accessibility of their products to pet owners.
Recent Developments:
In January 2023, TVM introduced DogStem, Europe's inaugural licensed stem cell therapy for canine osteoarthritis. Clinical trials demonstrated its efficacy, with improvements in gait and orthopedic examination, and owners reported enhanced mobility and quality of life for their pets, lasting up to eighteen months.
In May 2019, Elanco launched Galliprant, a new treatment for canine osteoarthritis pain, in the UK. Galliprant, a piprant, targets the EP4 receptor, reducing pain and inflammation without affecting gastrointestinal and kidney functions, offering a promising solution for managing OA discomfort in dogs.
In February 2024, Rejuvenate Bio partnered with a leading animal health company to develop and commercialize groundbreaking gene therapy for canine osteoarthritis, aiming to address the condition's widespread prevalence and devastating consequences, potentially revolutionizing dog health.
Key Companies in the Market
Boehringer Ingelheim International GmbH
DAIICHI SANKYO COMPANY, LIMITED
Thorne
NUTRI-VET
American Regent, Inc.
DSM
Zoetis
National hog farmer
Novasep
Bayer AG
Matsun Nutrition
Key Coverage in the Canine arthritis treatment Industry Report
Demand Analysis for Canine Arthritis Management Injection
Key Mergers and Acquisitions in the Canine Arthritis Treatment Market
Best Canine Osteoarthritis Treatment in India
Demand Analysis for Canine Osteoarthritis Therapy
General Overview of Dog Arthritis Medication Side Effects
Canine arthritis treatment Market by Segmentation
By Treatment:
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
Opioids
Stem Cell Therapy
Allogeneic Stem Cells
Autologous Stem Cells
By Route of Administration:
Oral Canine Arthritis Treatment
Injectable Canine Arthritis Treatment
By Distribution Channel:
Veterinary Hospitals & Clinics
Retail Pharmacies
Drug Stores
e-Commerce
By Region:
North America
Latin America
Asia Pacific
Middle East and Africa (MEA)
Europe
Frequently Asked Questions
How much is the Canine Arthritis Treatment Market Currently Worth?
The global canine arthritis treatment market is expected to be worth US$ 2.50 billion by 2024.
What is the Sales Forecast for Canine Arthritis Treatments through 2034?
The market for canine arthritis treatments is expected to reach US$ 3.77 billion by 2034.
At what rate is the Canine Arthritis Treatment Market growing across the world?
The canine arthritis treatment market is growing at a CAGR of 4.20% from 2024 to 2034.
Who are the key Companies in the Canine Arthritis Treatment Market?
Boehringer Ingelheim International GmbH., DAIICHI SANKYO COMPANY, LIMITED, Thorne, NUTRI-VET, American Regent, Inc., DSM, etc. are some of the major players in the market for canine arthritis treatment.
What was the overall Global Value of the Canine Arthritis Treatment Market in 2023?
The global valuation for the canine arthritis treatment market in 2023 was US$ 2.52 billion.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023
4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Treatment
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Treatment, 2019 to 2023
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment, 2024 to 2034
5.3.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
5.3.2. Opioids
5.3.3. Stem Cell Therapy
5.3.4. Allogeneic Stem Cells
5.3.5. Autologous Stem Cells
5.4. Y-o-Y Growth Trend Analysis By Treatment, 2019 to 2023
5.5. Absolute $ Opportunity Analysis By Treatment, 2024 to 2034
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2019 to 2023
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2024 to 2034
6.3.1. Oral
6.3.2. Injectable
6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2019 to 2023
6.5. Absolute $ Opportunity Analysis By Route of Administration, 2024 to 2034
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2019 to 2023
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2024 to 2034
7.3.1. Veterinary Hospitals & Clinics
7.3.2. Retail Pharmacies
7.3.3. Drug Stores
7.3.4. E-Commerce
7.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023
7.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Treatment
9.2.3. By Route of Administration
9.2.4. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Treatment
9.3.3. By Route of Administration
9.3.4. By Distribution Channel
9.4. Key Takeaways
10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Treatment
10.2.3. By Route of Administration
10.2.4. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Treatment
10.3.3. By Route of Administration
10.3.4. By Distribution Channel
10.4. Key Takeaways
11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Treatment
11.2.3. By Route of Administration
11.2.4. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Treatment
11.3.3. By Route of Administration
11.3.4. By Distribution Channel
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Treatment
12.2.3. By Route of Administration
12.2.4. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Treatment
12.3.3. By Route of Administration
12.3.4. By Distribution Channel
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Treatment
13.2.3. By Route of Administration
13.2.4. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Treatment
13.3.3. By Route of Administration
13.3.4. By Distribution Channel
13.4. Key Takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Treatment
14.2.3. By Route of Administration
14.2.4. By Distribution Channel
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Treatment
14.3.3. By Route of Administration
14.3.4. By Distribution Channel
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Treatment
15.2.3. By Route of Administration
15.2.4. By Distribution Channel
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Treatment
15.3.3. By Route of Administration
15.3.4. By Distribution Channel
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Market Share Analysis, 2023
16.1.1.1. By Treatment
16.1.1.2. By Route of Administration
16.1.1.3. By Distribution Channel
16.2. Canada
16.2.1. Market Share Analysis, 2023
16.2.1.1. By Treatment
16.2.1.2. By Route of Administration
16.2.1.3. By Distribution Channel
16.3. Brazil
16.3.1. Market Share Analysis, 2023
16.3.1.1. By Treatment
16.3.1.2. By Route of Administration
16.3.1.3. By Distribution Channel
16.4. Mexico
16.4.1. Market Share Analysis, 2023
16.4.1.1. By Treatment
16.4.1.2. By Route of Administration
16.4.1.3. By Distribution Channel
16.5. Germany
16.5.1. Market Share Analysis, 2023
16.5.1.1. By Treatment
16.5.1.2. By Route of Administration
16.5.1.3. By Distribution Channel
16.6. UK
16.6.1. Market Share Analysis, 2023
16.6.1.1. By Treatment
16.6.1.2. By Route of Administration
16.6.1.3. By Distribution Channel
16.7. France
16.7.1. Market Share Analysis, 2023
16.7.1.1. By Treatment
16.7.1.2. By Route of Administration
16.7.1.3. By Distribution Channel
16.8. Spain
16.8.1. Market Share Analysis, 2023
16.8.1.1. By Treatment
16.8.1.2. By Route of Administration
16.8.1.3. By Distribution Channel
16.9. Italy
16.9.1. Market Share Analysis, 2023
16.9.1.1. By Treatment
16.9.1.2. By Route of Administration
16.9.1.3. By Distribution Channel
16.10. Poland
16.10.1. Market Share Analysis, 2023
16.10.1.1. By Treatment
16.10.1.2. By Route of Administration
16.10.1.3. By Distribution Channel
16.11. Russia
16.11.1. Market Share Analysis, 2023
16.11.1.1. By Treatment
16.11.1.2. By Route of Administration
16.11.1.3. By Distribution Channel
16.12. Czech Republic
16.12.1. Market Share Analysis, 2023
16.12.1.1. By Treatment
16.12.1.2. By Route of Administration
16.12.1.3. By Distribution Channel
16.13. Romania
16.13.1. Market Share Analysis, 2023
16.13.1.1. By Treatment
16.13.1.2. By Route of Administration
16.13.1.3. By Distribution Channel
16.14. India
16.14.1. Market Share Analysis, 2023
16.14.1.1. By Treatment
16.14.1.2. By Route of Administration
16.14.1.3. By Distribution Channel
16.15. Bangladesh
16.15.1. Market Share Analysis, 2023
16.15.1.1. By Treatment
16.15.1.2. By Route of Administration
16.15.1.3. By Distribution Channel
16.16. Australia
16.16.1. Market Share Analysis, 2023
16.16.1.1. By Treatment
16.16.1.2. By Route of Administration
16.16.1.3. By Distribution Channel
16.17. New Zealand
16.17.1. Market Share Analysis, 2023
16.17.1.1. By Treatment
16.17.1.2. By Route of Administration
16.17.1.3. By Distribution Channel
16.18. China
16.18.1. Market Share Analysis, 2023
16.18.1.1. By Treatment
16.18.1.2. By Route of Administration
16.18.1.3. By Distribution Channel
16.19. Japan
16.19.1. Market Share Analysis, 2023
16.19.1.1. By Treatment
16.19.1.2. By Route of Administration
16.19.1.3. By Distribution Channel
16.20. South Korea
16.20.1. Market Share Analysis, 2023
16.20.1.1. By Treatment
16.20.1.2. By Route of Administration
16.20.1.3. By Distribution Channel
16.21. GCC Countries
16.21.1. Market Share Analysis, 2023
16.21.1.1. By Treatment
16.21.1.2. By Route of Administration
16.21.1.3. By Distribution Channel
16.22. South Africa
16.22.1. Market Share Analysis, 2023
16.22.1.1. By Treatment
16.22.1.2. By Route of Administration
16.22.1.3. By Distribution Channel
16.23. Israel
16.23.1. Market Share Analysis, 2023
16.23.1.1. By Treatment
16.23.1.2. By Route of Administration
16.23.1.3. By Distribution Channel
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Treatment
17.3.3. By Route of Administration
17.3.4. By Distribution Channel
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Boehringer Ingelheim International GmbH.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. DAIICHI SANKYO COMPANY, LIMITED
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Thorne
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Nutri-Vet
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. American Regent, Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. DSM
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Zoetis
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. National Hog Farmer
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Novasep
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Bayer AG
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Matsun Nutrition
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
19. Assumptions & Acronyms Used20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034
Table 4: Global Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034
Table 8: North America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 10: Latin America Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 11: Latin America Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034
Table 12: Latin America Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Western Europe Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 15: Western Europe Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034
Table 16: Western Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 18: Eastern Europe Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 19: Eastern Europe Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034
Table 20: Eastern Europe Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034
Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: East Asia Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 27: East Asia Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034
Table 28: East Asia Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Treatment, 2019 to 2034
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Route of Administration, 2019 to 2034
Table 32: Middle East and Africa Market Value (US$ Million) Forecast by Distribution Channel, 2019 to 2034
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Route of Administration, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 8: Global Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 9: Global Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 10: Global Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 11: Global Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034
Figure 12: Global Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 13: Global Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 14: Global Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 17: Global Market Attractiveness by Treatment, 2024 to 2034
Figure 18: Global Market Attractiveness by Route of Administration, 2024 to 2034
Figure 19: Global Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 20: Global Market Attractiveness by Region, 2024 to 2034
Figure 21: North America Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 22: North America Market Value (US$ Million) by Route of Administration, 2024 to 2034
Figure 23: North America Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 24: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 28: North America Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 29: North America Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 30: North America Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 31: North America Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 34: North America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 37: North America Market Attractiveness by Treatment, 2024 to 2034
Figure 38: North America Market Attractiveness by Route of Administration, 2024 to 2034
Figure 39: North America Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 40: North America Market Attractiveness by Country, 2024 to 2034
Figure 41: Latin America Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 42: Latin America Market Value (US$ Million) by Route of Administration, 2024 to 2034
Figure 43: Latin America Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 44: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 48: Latin America Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 54: Latin America Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 57: Latin America Market Attractiveness by Treatment, 2024 to 2034
Figure 58: Latin America Market Attractiveness by Route of Administration, 2024 to 2034
Figure 59: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 60: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 61: Western Europe Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 62: Western Europe Market Value (US$ Million) by Route of Administration, 2024 to 2034
Figure 63: Western Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 64: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 68: Western Europe Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 71: Western Europe Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034
Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 74: Western Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 75: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 77: Western Europe Market Attractiveness by Treatment, 2024 to 2034
Figure 78: Western Europe Market Attractiveness by Route of Administration, 2024 to 2034
Figure 79: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 80: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 81: Eastern Europe Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 82: Eastern Europe Market Value (US$ Million) by Route of Administration, 2024 to 2034
Figure 83: Eastern Europe Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034
Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 94: Eastern Europe Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 97: Eastern Europe Market Attractiveness by Treatment, 2024 to 2034
Figure 98: Eastern Europe Market Attractiveness by Route of Administration, 2024 to 2034
Figure 99: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 100: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 101: South Asia and Pacific Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 102: South Asia and Pacific Market Value (US$ Million) by Route of Administration, 2024 to 2034
Figure 103: South Asia and Pacific Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034
Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 117: South Asia and Pacific Market Attractiveness by Treatment, 2024 to 2034
Figure 118: South Asia and Pacific Market Attractiveness by Route of Administration, 2024 to 2034
Figure 119: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 120: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 121: East Asia Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 122: East Asia Market Value (US$ Million) by Route of Administration, 2024 to 2034
Figure 123: East Asia Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 124: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 128: East Asia Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 129: East Asia Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 131: East Asia Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 134: East Asia Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 135: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 137: East Asia Market Attractiveness by Treatment, 2024 to 2034
Figure 138: East Asia Market Attractiveness by Route of Administration, 2024 to 2034
Figure 139: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 140: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 141: Middle East and Africa Market Value (US$ Million) by Treatment, 2024 to 2034
Figure 142: Middle East and Africa Market Value (US$ Million) by Route of Administration, 2024 to 2034
Figure 143: Middle East and Africa Market Value (US$ Million) by Distribution Channel, 2024 to 2034
Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Treatment, 2019 to 2034
Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Treatment, 2024 to 2034
Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Treatment, 2024 to 2034
Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Route of Administration, 2019 to 2034
Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Route of Administration, 2024 to 2034
Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Route of Administration, 2024 to 2034
Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by Distribution Channel, 2019 to 2034
Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034
Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034
Figure 157: Middle East and Africa Market Attractiveness by Treatment, 2024 to 2034
Figure 158: Middle East and Africa Market Attractiveness by Route of Administration, 2024 to 2034
Figure 159: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034
Figure 160: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
